Patents by Inventor Clary B. Clish

Clary B. Clish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aspirin-triggered lipid mediators
    Patent number: 8349896
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with diseases, including ischemia.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: January 8, 2013
    Assignee: The Brigham and Womens's Hospital, Inc.
    Inventors: Charles N. Serhan, Clary B. Clish
  • ASPIRIN-TRIGGERED LIPID MEDIATORS
    Publication number: 20100216882
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with diseases, including ischemia.
    Type: Application
    Filed: February 17, 2010
    Publication date: August 26, 2010
    Inventors: Charles N. Serhan, Clary B. Clish
  • Aspirin-triggered lipid mediators
    Patent number: 7737178
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: June 15, 2010
    Assignee: The Brigham and Woman's Hospital, Inc.
    Inventors: Charles N. Serhan, Clary B. Clish
  • Aspirin-triggered lipid mediators
    Patent number: 7709669
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Grant
    Filed: January 18, 2006
    Date of Patent: May 4, 2010
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Charles N. Serhan, Clary B. Clish
  • Aspirin-Triggered Lipid Mediators
    Publication number: 20090149538
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Application
    Filed: December 18, 2008
    Publication date: June 11, 2009
    Inventors: Charles N. Serhan, Clary B. Clish
  • Aspirin-triggered lipid mediators
    Patent number: 7053230
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: May 30, 2006
    Inventors: Charles N. Serhan, Clary B. Clish
  • Aspirin-triggered lipid mediators
    Publication number: 20040059144
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Application
    Filed: September 12, 2003
    Publication date: March 25, 2004
    Inventors: Charles N. Serhan, Clary B. Clish
  • Aspirin-triggered lipid mediators
    Patent number: 6670396
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: December 30, 2003
    Assignee: Brigham and Women's Hospital
    Inventors: Charles N. Serhan, Clary B. Clish
  • Aspirin-triggered lipid mediators
    Publication number: 20020055538
    Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
    Type: Application
    Filed: February 16, 2001
    Publication date: May 9, 2002
    Inventors: Charles N. Serhan, Clary B. Clish